The National Institutes of Health (NIH) announced that it will offer grant extensions to eligible grantees affected by COVID-19.
The COVID-19 pandemic, and subsequent mitigation measures, have severely impacted progress in the field of medical research. In support of early-career scientists, NIH is allowing NIH Fellowship and NIH Career Development award recipients the opportunity to request no-cost extensions and funded extensions.
Requests should outline how the COVID-19 pandemic has adversely impacted the grant recipient’s training and career development. NIH and authorized organization officials will consider requests on a case-by-case basis, subject to the availability of funds.
Read the full notice for more information.
Surge of antidepressant use seen among female adolescents during COVID-19
March 7th 2024A study revealed a significant increase in antidepressant prescriptions among adolescents and young adults during the COVID-19 pandemic, particularly among female adolescents, indicating exacerbation of pre-existing mental health challenges.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Read More
Maternal COVID-19 vaccination deemed safe for infant neurodevelopment up to 18 months
January 23rd 2024A recent study found that in utero exposure to maternal COVID-19 vaccination poses no increased risk for neurodevelopmental impairment in infants up to 18 months of age, addressing concerns about the impact of vaccine exposure on unborn children.
Read More